May/June 2015

Biopharma Asia

May/June 2015 | Volume 4 Issue 3


Critical Aspects and Risks in Implementing Single-Use Technologies in Flexible Facilities

By: Adam Goldstein, Principal Scientist Genentech/Roche Carl Johnson, Sr. Principal Engine...


The Paperless Laboratory: A Way Into Process Optimisation

By: Peter Boogaard, CEO Industrial Lab Automation www.industriallabautomation.com peterboo...


NIR In-Line Monitoring for Drug Product Continuous Process: From Understanding to Control

By: Yang (Angela) Liu, Senior Principal Scientist in the Analytical Development group Pfiz...


Study of Pharmaceutical Drug-Excipient Interaction by FTIR and Raman Spectroscopy

By: Ming Huang, Research Investigator II Robert Wethman, Senior Research Scientist John Wa...


Incorporating QbD Excipient Variability into Pharmaceutical Drug Product Design and Develo...

By: Joseph Kushner, IV, Ph.D. Senior Principal Scientist Drug Product Design Worldwide Re...